Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Keros Therapeutics (KROS) Tax Rate (2020 - 2025)

Keros Therapeutics' Tax Rate history spans 4 years, with the latest figure at 6.06% for Q4 2025.

  • For Q4 2025, Tax Rate rose 672.0% year-over-year to 6.06%; the TTM value through Dec 2025 reached 5.31%, up 547.0%, while the annual FY2025 figure was 5.31%, 547.0% up from the prior year.
  • Tax Rate reached 6.06% in Q4 2025 per KROS's latest filing, down from 16.36% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 16.36% in Q3 2025 to a low of 40.46% in Q4 2021.
  • Average Tax Rate over 3 years is 0.72%, with a median of 3.12% recorded in 2021.
  • Peak YoY movement for Tax Rate: plummeted -174bps in 2021, then surged 672bps in 2025.
  • A 3-year view of Tax Rate shows it stood at 40.46% in 2021, then skyrocketed by 98bps to 0.66% in 2024, then soared by 1024bps to 6.06% in 2025.
  • Per Business Quant, the three most recent readings for KROS's Tax Rate are 6.06% (Q4 2025), 16.36% (Q3 2025), and 6.75% (Q2 2025).